In the present study, we confirmed the existence of a group of SETD4-positive cells, defined as qLCSCs, in tumor tissues from early-stage NSCLC patients and found that the proportion of SETD4-positive qLCSCs in advanced-stage patients was significantly higher than that in early-stage patients. The gene discussed is SETD4; the disease is non-small cell lung carcinoma.